Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
The Annals of Pharmacotherapy|February 28, 2018
Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week DataAmedeo Ferdinando Capetti, Maria Vittoria Cossu, Gaetana Sterrantino, et al.BMC Gastroenterology|February 23, 2010
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trialFabrizio Mecenate, Adriano M Pellicelli, Giuseppe Barbaro, et al.HIV Clinical Trials|March 21, 2019
Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjectsAmedeo F Capetti, Giuseppe V De Socio, Maria V Cossu, et al.BMC Infectious Diseases|October 2, 2017
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational dataAmedeo F Capetti, Maria Vittoria Cossu, Giancarlo Orofino, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2011
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates)Piero L Almasio, Sergio Babudieri, Giorgio Barbarini, et al.Clinical Therapeutics|March 18, 2008
Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label studyAdriano M Pellicelli, Giuseppe Barbaro, Ruggiero Francavilla, et al.Journal of Hepatology|September 17, 2010
Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3Alessandra Mangia, Franco Bandiera, Giuseppe Montalto, et al.World Journal of Hepatology|November 30, 2011
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphomaAdriano M Pellicelli, Massimo Marignani, Valerio Zoli, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2009
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric studyClaudio Puoti, Adriano M Pellicelli, Mario Romano, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2016
Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life studyAdriano M Pellicelli, Valeria Pace Palitti, Pascal Vignally, et al.Pageof 5